Compounds > 2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide
Page last updated: 2024-09-03

2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide and Urinary Bladder Neoplasms

2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide has been researched along with Urinary Bladder Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chapple, CR; Chess-Williams, R; Korstanje, C; Martin, SW1

Other Studies

1 other study(ies) available for 2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide and Urinary Bladder Neoplasms

ArticleYear
In vitro investigation of the bladder-vascular selectivity of levcromakalim and YM934 in human tissues.
    BJU international, 1999, Volume: 83, Issue:9

    Topics: Benzoxazines; Cromakalim; Cyclic N-Oxides; Cystectomy; Humans; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; Oxazines; Urinary Bladder; Urinary Bladder Neoplasms

1999